Advancing Precision Oncology: New NGS Assay for Comprehensiv

Agilent Technologies Inc has unveiled the Agilent SureSelect Cancer CGP Assay, a next-generation sequencing (NGS) panel designed for somatic variant profiling in a wide range of solid tumour types. Click to read more...

Related Keywords

Glasgow , Glasgow City , United Kingdom , Alistair Ritchie , Ronda Allen , Glasgow Precision Oncology Laboratory , Agilent Technologies Inc , Genomics Division At Agilent , Agilent Sureselect Cancer , Sureselect Cancer , Alissa Interpret , Vice President , General Manager , Genomics Division , Sequencing Laboratory Manager , Agilent Sureselect , Cancer , Agilent , Sureselect , Biomarkers , Profiling , Olid , Humour , Linical , Comprehensive , Workflow ,